KRISTAL LYN: Open Payments
NPI 1477147296 · ATLANTIS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$888 in 36 payments from 12 companies in 2025. Trend: 2023 $57 · 2024 $514 · 2025 $888
Food & beverage: $888
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 13 | $293 |
| Novo Nordisk Inc | 5 | $158 |
| E.R. Squibb & Sons, L.L.C. | 5 | $99 |
| CVRx, Inc. | 2 | $68 |
| Philips North America LLC | 1 | $62 |
| Amgen Inc. | 2 | $38 |
| Alnylam Pharmaceuticals Inc. | 2 | $33 |
| Lilly USA, LLC | 2 | $32 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $31 |
| Ardelyx, Inc. | 1 | $28 |
Products named: LEQVIO, Wegovy, CAMZYOS, Barostim Neo System, Ambulatory Monitoring & Diagnostics Undivided, REPATHA, Ozempic, ONPATTRO.
Industry payments across FL — which companies pay providers there.
